Riegel Barbara , Abshire Saylor Martha
Presentation/Board Number:
Scientific Sessions 2024
Moving the Needle Towards Scaling Interventions: Non-pharmacological Intervention Science
Pellegrini Cara , Ekeruo Ijeoma
Presentation/Board Number:
Scientific Sessions 2024
Atrial Fibrillation and Stroke: From Wearables and Implantables to Prevention and Outcomes - CRYSTAL Clear or Clear as Mud?
Reynolds Harmony
Presentation/Board Number:
Scientific Sessions 2024
ACS Beyond Plaque Rupture: Meet the Experts
Messe Steven , Ross Lindsey , Olaiya Muideen , Gall Seana
Presentation/Board Number:
International Stroke Conference 2025
Leveraging Real-World Evidence to Enhance Stroke Outcomes
Everett Marlon , Dorsey Chelsea
Presentation/Board Number:
Scientific Sessions 2024
Unequal Hearts: Tackling Disparities in Cardiovascular Health (AHA Joint Session with the Association of Black Cardiologists)
Brewster Luke
Presentation/Board Number:
Scientific Sessions 2024
PVD Lecture and the Jay D. Coffman Early Career Investigator Award Competition
Zhao Li , Huang Fangze , Zhao Lingna , Liu Deshen , He Xiao-xia , Lu Jun , Zheng Shao-yi , Peng Qin-bao , Liu Xiu
Presentation/Board Number: VD3
Scientific Sessions 2024
Best of AHA Specialty Conferences: Vascular Discovery 2024
Zhao Jiahui , Tian Hao , Liu Liping , Nie Ximing , Zheng Lina
Presentation/Board Number: LBP15
International Stroke Conference 2025
Late-Breaking Science Posters
Awad Issam
Presentation/Board Number:
International Stroke Conference 2025
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)
Goyal Mayank
Presentation/Board Number:
International Stroke Conference 2025
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)
Zhang Xuening
Presentation/Board Number:
International Stroke Conference 2025
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial (LB17) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)
Wu Bo
Presentation/Board Number:
International Stroke Conference 2025
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial (LB17) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)